Literature DB >> 12017684

Diabetic nephropathy.

.   

Abstract

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 12017684

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


  11 in total

1.  Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes.

Authors:  Y Chen; J J Wang; J Li; K I Hosoya; R Ratan; T Townes; S X Zhang
Journal:  Diabetologia       Date:  2012-06-04       Impact factor: 10.122

2.  Newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign.

Authors:  Hoon Park; Young Gyun Kim; Jong Wook Lee; Jong Seok Park
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

3.  Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies.

Authors:  Alok Shiomurti Tripathi; Ajay Kumar Timiri; Papiya Mitra Mazumder; Anil Chandewar
Journal:  J Mol Model       Date:  2015-10-01       Impact factor: 1.810

4.  Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy.

Authors:  Sarah X Zhang; Emily Sanders; Joshua J Wang
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-18

5.  SOD2 gene Val16Ala polymorphism is associated with macroalbuminuria in Mexican type 2 diabetes patients: a comparative study and meta-analysis.

Authors:  Iván de Jesús Ascencio-Montiel; Esteban J Parra; Adán Valladares-Salgado; Jaime H Gómez-Zamudio; Jesús Kumate-Rodriguez; Jorge Escobedo-de-la-Peña; Miguel Cruz
Journal:  BMC Med Genet       Date:  2013-10-11       Impact factor: 2.103

6.  Renal Histology in Diabetic Patients.

Authors:  Yassir Zajjari; Taoufiq Aatif; Kawtar Hassani; Sanaa Benbria; Driss El Kabbaj
Journal:  Saudi J Med Med Sci       Date:  2018-12-14

7.  Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study.

Authors:  Rong Shi; Zheyun Niu; Birong Wu; Taotao Zhang; Dujie Cai; Hui Sun; Yuhong Hu; Ruohui Mo; Fan Hu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-20       Impact factor: 3.168

8.  MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes.

Authors:  Mohamed Fouad; Ibrahim Salem; Khaled Elhefnawy; Nermin Raafat; Amal Faisal
Journal:  Indian J Nephrol       Date:  2019-12-27

9.  Renal histology in diabetic nephropathy: A novel perspective.

Authors:  M Sahay; R K Mahankali; K Ismal; P S Vali; R K Sahay; G Swarnalata
Journal:  Indian J Nephrol       Date:  2014-07

10.  Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study.

Authors:  Yuhong Hu; Rong Shi; Ruohui Mo; Fan Hu
Journal:  Aging (Albany NY)       Date:  2020-06-02       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.